About UsMembershipMarketplaceResourcesGlobal Business Atlas
Top AI CompaniesTop Blockchain Influencers & AuthorsTop Global Digital AgenciesBusinessabc Country IndexesTop Accelerators and Chambers of CommerceTop Public Companies by MarketcapBusinessabc Education IndexesTop Malaysian Companies
DirectoryCompaniesLeadersInvestorsUniversitiesOrganisations
Loading wiki page…

Get Your Own Businessabc AI Visibility ID

Boost AI visibility, credibility, and discoverability

Learn More
Last Updated: 2026
Jiangsu Hengrui Medicine image

Jiangsu Hengrui Medicine

Rank#596
Market Cap42.78B
CountryChina
Summary
History
Mission
Vision
References
Summaryarrow

Jiangsu Hengrui Medicine Co., Ltd., a pharmaceutical company, researches, develops, manufactures, and commercializes medicine worldwide. The company is developing Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403 for oncology, metabolic, pain, autoimmune, and other indications. The company was founded in 1970 and is based in Lianyungang, China.

Historyarrow

Founded in 1970, Jiangsu Hengrui Pharmaceuticals was originally state-owned and called Lianyungang Pharmaceutical Factory. Headquartered in Lianyungang, Jiangsu, it was established in its current form in 1977. 

Jiangsu Hengrui Medicine develops, manufactures, and markets a variety of medicines and medical packing materials. The Company's products include anti-tumour medicines, painkillers, anti-infection medicines, aluminium foil, and other related products. Taking the slogan “Science & Technology for a Better Life”, Hengrui Medicine is dedicated to researching, developing, and promoting innovative medicine with high quality. They help doctors to solve clinical problems, help patients be cured, and help improve the standard of health for all humanity.

The company was listed on the Shanghai Stock Exchange in 2000 and now has locations in China, the United States, Germany, Switzerland, Japan, and Australia.

Missionarrow

“Promote a healthier life for humankind through advancements in science.”

 

Visionarrow

“Become a global biopharmaceutical group through innovation.”

Referencesarrow

https://en.wikipedia.org/wiki/Jiangsu_Hengrui_Medicine

https://www.crunchbase.com/organization/jiangsu-hengrui-medicine

https://sec.report/CIK/0001631710

https://finance.yahoo.com/quote/600276.SS/

https://www.globaldata.com/company-profile/jiangsu-hengrui-medicine-co-ltd/

https://companiesmarketcap.com/largest-companies-by-revenue/

https://www.globaldata.com/company-profile/jiangsu-hengrui-medicine-co-ltd/

https://www.forbes.com/companies/jiangsu-hengrui-medicine/

https://www.bloomberg.com/profile/company/600276:CH

https://www.statista.com/statistics/1181113/chinese-pharmaceuticals-jiangsu-hengrui-medicine-annual-revenue/

Share

Leadership team
M
Ms. Su Mei Jiang (Exec. Deputy GM & Director)
M
Mr. Jie Ping Sun (Deputy GM & Director)
Products / Services
Biotechnology, Health Care, Manufacturing, Pharmaceutical
Number of Employees
20,000 - 50,000
Established
1970-03-10
Net Income
S_500M_1B
Revenue
$1B+
Traded as
600276.SS
Website
https://www.hrs.com.cn
Social Media
linkedin
Last Updated: 2026
Logo

Businessabc provides digital business directory, digital blockchain AI certification, resources, and marketplace for businesses, organisations, and professionals.

Contacts

Email
Contact

Follow Us

Created Produced

Partner logo
Partner logo

Tech AI Media Platforms

Partner logo
Partner logo
Partner logo
Partner logo
Partner logo
Partner logo

Copyright 2026 © Businessabc powered by

Powered by ztudium group

DisclaimerPrivacy PolicyTerms of Service
Partner logo
Partner logo
Partner logo
Partner logo
Partner logo
Partner logo